| Literature DB >> 31257031 |
Diego Adhemar Jaitin1, Lorenz Adlung1, Christoph A Thaiss2, Assaf Weiner1, Baoguo Li1, Hélène Descamps3, Patrick Lundgren3, Camille Bleriot4, Zhaoyuan Liu5, Aleksandra Deczkowska1, Hadas Keren-Shaul1, Eyal David1, Niv Zmora1, Shai Meron Eldar6, Nir Lubezky6, Oren Shibolet7, David A Hill8, Mitchell A Lazar9, Marco Colonna10, Florent Ginhoux11, Hagit Shapiro1, Eran Elinav12, Ido Amit13.
Abstract
Immune cells residing in white adipose tissue have been highlighted as important factors contributing to the pathogenesis of metabolic diseases, but the molecular regulators that drive adipose tissue immune cell remodeling during obesity remain largely unknown. Using index and transcriptional single-cell sorting, we comprehensively map all adipose tissue immune populations in both mice and humans during obesity. We describe a novel and conserved Trem2+ lipid-associated macrophage (LAM) subset and identify markers, spatial localization, origin, and functional pathways associated with these cells. Genetic ablation of Trem2 in mice globally inhibits the downstream molecular LAM program, leading to adipocyte hypertrophy as well as systemic hypercholesterolemia, body fat accumulation, and glucose intolerance. These findings identify Trem2 signaling as a major pathway by which macrophages respond to loss of tissue-level lipid homeostasis, highlighting Trem2 as a key sensor of metabolic pathologies across multiple tissues and a potential therapeutic target in metabolic diseases.Entities:
Keywords: Alzheimer disease; Trem2 pathway; fatty liver diseases; immunology; macrophages; metabolic diseases; metabolism; obesity; single-cell genomics; systems biology
Mesh:
Substances:
Year: 2019 PMID: 31257031 PMCID: PMC7068689 DOI: 10.1016/j.cell.2019.05.054
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582